多发性硬化症的早期发现 - 临床特征
Vesna Suknjaja1,2, Lorand Sakalaš1,2, Miroslav Ilin3
1University Clinical Center of Vojvodina, Department of Neuroinflammation and Demyelinization, Novi Sad, Serbia.
Acta clinica Croatica
|February 17, 2025
概括
儿童多发性硬化症 (MS) 的发病带来了独特的挑战. 这项研究发现,儿童早期出现的多发性硬化症症状和疾病的发展过程与成人相似.
科学领域:
- 神经学 神经学
- 儿科神经学 儿科神经学
- 神经免疫学 神经免疫学
背景情况:
- 儿童发病的多发性硬化症 (MS) 呈现出诊断上的困难.
- 了解早期发病的MS对于及时诊断和管理至关重要.
- 将儿科多发性硬化与成人多发性硬化进行比较,可以了解疾病的异质性.
研究的目的:
- 分析儿童早期MS的参数,与成人MS患者相比.
- 调查初始症状和疾病过程中的差异和相似之处.
- 加强儿童多发性硬化症的诊断和治疗策略.
主要方法:
- 对患有中枢神经系统脱髓化疾病的患者的回顾性分析.
- 分类为儿科 (发病年龄<18岁,n=52) 和成人 (20-55岁) 组.
- 初始症状,多症状发作和第二次复发时间的比较.
主要成果:
- 儿童很少出现多症状发作 (p=0.020).
- 儿童的初始症状:视神经炎 (35.3%) 和视力衰竭 (35.3%).
- 成年人的初始症状:感官障碍 (41.6%) 和金字塔症状 (37.6%).
- 第二次复发发生在78.4%的儿科患者 (中位数为12个月) 和78.2%的成人 (中位数为9个月) 中.
结论:
- 儿童MS的初始临床表现与成人相似.
- 疾病过程参数,包括复发率,显示儿科和成人MS之间的相似性.
- 研究结果表明,必须采取统一的方法来治疗多发性硬化症,同时考虑到特定年龄的细微差别.
相关概念视频
01:15Parkinson's Disease: Overview
429
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
429
01:19Autism Spectrum Disorder
56
Autism spectrum disorder (ASD) is a neurodevelopmental condition marked by persistent deficits in social communication and interaction alongside restrictive and repetitive behaviors or interests. ASD is sometimes accompanied by intellectual impairment.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
56
01:26Alzheimer's Disease: Overview
429
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
429
01:17Schizophrenia
57
Schizophrenia, a term introduced by Swiss psychiatrist Eugen Bleuler in 1911, describes a severe psychological disorder marked by profound disruptions in attention, thought processes, language, emotion, and interpersonal relationships. The core feature of schizophrenia is psychosis — a state characterized by a fundamental detachment from reality. This disconnection manifests through distorted logic, impaired perception, and atypical behavior, severely affecting the lives of those...
57
01:29Biological Causes of Schizophrenia
35
Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
35